China AML vs EU Competition Law: Which Competition Law Approach?

Introduction

Foreign companies operating in both China and the European Union face the challenge of navigating two distinct competition law regimes that, while sharing certain foundational principles, differ significantly in their enforcement philosophy, procedural approaches, and substantive legal standards. China’s Anti-Monopoly Law (AML), enacted in 2008 and substantially amended in 2022, and EU competition law, which traces its origins to the Treaty of Rome in 1957 and has been shaped by decades of jurisprudence from the European Commission and the European Court of Justice, represent two of the most influential antitrust systems globally. This comparison provides a structured analysis of the key differences and similarities between these two regimes to help foreign businesses determine which competition law approach best suits their compliance and strategic needs in each jurisdiction.

The choice between understanding China’s AML and EU competition law is not a matter of selecting one framework over the other, as both regimes may apply concurrently to transactions and conduct that have effects in both jurisdictions. Rather, the question is which approach each jurisdiction takes on specific competition law issues, and how businesses must adapt their compliance strategies accordingly. This article compares the two regimes across six critical dimensions: regulatory architecture, merger control, abuse of dominance, anti-competitive agreements, enforcement mechanisms, and penalties.

Regulatory architecture and enforcement bodies

The institutional framework for competition law enforcement differs markedly between China and the EU. China’s AML enforcement was historically fragmented across three agencies until 2018, when the Anti-Monopoly Commission under the State Council was consolidated into the State Administration for Market Regulation (SAMR). SAMR now serves as the unified antitrust enforcement authority for all aspects of the AML, including merger review, investigation of monopoly agreements, abuse of dominance cases, and abuse of administrative power. This centralized model gives SAMR broad authority but also means that political and industrial policy considerations can influence enforcement decisions more directly than in the EU.

The European Commission’s Directorate-General for Competition (DG COMP) similarly has centralized authority to enforce EU competition law, but its decision-making is subject to more robust judicial oversight from the General Court and the European Court of Justice. National competition authorities in each EU member state also retain concurrent enforcement powers under the European Competition Network (ECN), creating a multi-layered enforcement structure. The EU model is characterized by greater procedural transparency, more extensive due process protections, and a more established body of case law that provides predictability for businesses.

Merger control: Thresholds and review standards

Both regimes require mandatory pre-merger notification for transactions that meet specified turnover thresholds, but the standards for intervention and the scope of review differ substantially. Under China’s AML, a concentration must be notified if the combined global turnover of all parties exceeds RMB 12 billion and at least two parties each had Chinese turnover exceeding RMB 800 million. The substantive test is whether the concentration “has or may have the effect of eliminating or restricting competition.” Crucially, SAMR also considers industrial policy factors, including whether the transaction aligns with China’s national development priorities, which can influence the outcome of merger review in ways that go beyond pure competition analysis.

Under EU competition law, the notification thresholds are based on worldwide and EU-wide turnover: a concentration is notifiable if the combined worldwide turnover of all parties exceeds EUR 5 billion and at least two parties each have EU-wide turnover exceeding EUR 250 million. Alternative thresholds apply to smaller transactions with significant national impact. The substantive test under the EU Merger Regulation is the “Significant Impediment to Effective Competition” (SIEC) test, which focuses on whether the transaction would significantly impede effective competition in the common market or a substantial part of it. Unlike China’s AML, the EU test is applied strictly on competition grounds, with limited scope for non-competition considerations such as industrial policy.

A notable difference is China’s “stop the clock” mechanism under the 2022 AML amendments, which allows SAMR to extend review periods indefinitely in cases where parties delay providing required information. This gives SAMR significantly more leverage over merging parties than the EU’s fixed statutory review timelines. Additionally, China’s recent implementation of a simplified procedure for non-problematic concentrations has brought its merger review more in line with the EU’s simplified procedure, although China’s version applies to a narrower range of transactions.

Treatment of monopoly agreements and cartels

The prohibition of anti-competitive agreements is a core pillar of both regimes. Article 17 of China’s AML prohibits horizontal monopoly agreements among competitors, including price fixing, output restrictions, market allocation, restrictions on purchase of new technology, and collective boycotts. Article 18 prohibits vertical monopoly agreements, including resale price maintenance (RPM) and other vertical restrictions. The 2022 amendments introduced a “hub-and-spoke” provision that extends liability to parties that facilitate anti-competitive agreements without directly participating in them.

EU competition law under Article 101 TFEU similarly prohibits agreements between undertakings that have as their object or effect the prevention, restriction, or distortion of competition. The EU regime distinguishes between “object” restrictions (such as price fixing and market sharing, which are presumed to be anti-competitive) and “effect” restrictions (which require an economic analysis of actual or potential competitive harm). This distinction gives EU law greater analytical nuance than China’s AML, which tends to treat most horizontal restrictions as per se violations.

Abuse of dominance standards

Both China’s AML (Article 22) and EU competition law (Article 102 TFEU) prohibit abuse of a dominant market position. The definitions of “dominant position” share common elements, including market share thresholds (a rebuttable presumption of dominance arises at 50 percent market share under China’s AML, while EU case law typically applies dominance starting at 40 to 50 percent depending on market structure). Both regimes prohibit similar abusive conduct, including excessive pricing, predatory pricing, refusal to deal, tying and bundling, and discriminatory treatment.

However, there are notable differences in how each regime approaches abuse of dominance. China’s AML places greater emphasis on the “without justification” element, which allows SAMR to consider broader economic and policy justifications for conduct that might otherwise be considered abusive. This flexibility means that SAMR has significant discretion to tailor its enforcement to specific market conditions and policy objectives. The EU regime, while also allowing for objective justifications, applies a more rigorously economic analysis, focusing on whether the conduct has the effect of foreclosing equally efficient competitors from the market.

The EU’s “as efficient competitor” test, developed through case law such as Post Danmark and Intel, represents a more economically sophisticated approach to abuse of dominance analysis than China’s AML currently employs. China’s enforcement has historically focused more on the formal elements of dominance and abuse, although recent decisions show increasing engagement with economic analysis and effects-based approaches. The divergence is narrowing as SAMR develops its enforcement capacity and draws on international best practices, but significant differences remain in practice.

Enforcement mechanisms and penalties

The enforcement powers and penalty regimes under China’s AML and EU competition law have converged in recent years but retain important distinctions. The 2022 amendments to China’s AML significantly increased maximum fines: up to 10 percent of the preceding year’s turnover for monopoly agreements and abuse of dominance, and up to RMB 5 million for procedural violations such as gun-jumping. For serious violations, SAMR can also order disgorgement of illegal gains and, in the case of monopoly agreements, the revocation of the business’s corporate registration.

Under EU competition law, the maximum fine for substantive violations is up to 10 percent of the total worldwide turnover of the undertaking in the preceding business year, aligning closely with China’s AML. The European Commission has imposed record fines exceeding EUR 4 billion in individual cases, demonstrating its willingness to use its fining powers aggressively. EU law also provides for private damages actions through national courts, which has become an increasingly important enforcement channel following the EU Damages Directive of 2014.

A significant procedural difference is that China’s AML enforcement relies predominantly on administrative decisions, with limited scope for private litigation. Private antitrust litigation in China has grown but remains less developed than in the EU, where private damages actions represent an established and growing avenue for competition law enforcement. EU law also provides stronger protections for defendants’ procedural rights, including more extensive rights of access to the file, oral hearings, and judicial review.

International cooperation and extraterritorial reach

Both China and the EU assert extraterritorial jurisdiction over conduct that produces effects within their respective territories. China’s AML expressly applies to conduct outside China that has the effect of eliminating or restricting competition in the Chinese domestic market. SAMR has actively exercised this jurisdiction in reviewing cross-border transactions and investigating foreign companies for conduct occurring outside China that affects Chinese markets.

The EU has pioneered the extraterritorial application of competition law through the “effects doctrine,” first articulated in the Wood Pulp case and refined in subsequent decisions such as Intel and Google Shopping. DG COMP routinely reviews mergers and investigates conduct by non-EU companies whose activities affect EU markets. Both regimes cooperate through bilateral competition law agreements and participation in multilateral forums such as the International Competition Network (ICN) and the OECD Competition Committee.

However, China’s approach to international cooperation has become more selective in recent years, with less formal engagement with some international antitrust networks and a greater emphasis on bilateral cooperation with selected jurisdictions. This contrasts with the EU’s active and institutionalized approach to international cooperation, which includes multiple bilateral agreements, technical assistance programs, and active participation in ICN working groups.

Practical implications for foreign businesses

For foreign businesses operating in both China and the EU, the key practical implications of the differences between the two competition law regimes include:

1. Dual filing obligations: Many cross-border transactions require merger filings in both jurisdictions, often with different timelines, information requirements, and substantive standards. Coordinating parallel reviews in China and the EU requires careful planning and allocation of internal resources.
2. Compliance program design: A compliance program designed for EU competition law may not adequately address China-specific AML requirements. Companies should develop jurisdiction-specific compliance modules that address the nuances of each regime, particularly regarding vertical agreements and the role of industrial policy considerations.
3. Risk assessment differences: Conduct that may be permissible under EU competition law (for example, certain forms of vertical cooperation or information exchange) may be more strictly scrutinized under China’s AML, and vice versa. Companies should conduct jurisdiction-specific antitrust risk assessments for their commercial operations.
4. Investigation preparedness: The procedural differences between dawn raids, document requests, and investigative interviews in China versus the EU require different response strategies. Companies should have separate crisis management protocols for SAMR and European Commission investigations.
5. Leniency strategy: The availability and terms of leniency differ between the two regimes, requiring different approaches to self-reporting and cooperation in cartel investigations.

Conclusion

China’s AML and EU competition law share fundamental principles rooted in the protection of competition, but they diverge significantly in their enforcement philosophy, procedural frameworks, and the extent to which non-competition considerations influence outcomes. China’s AML is characterized by greater administrative discretion, the integration of industrial policy objectives, and a developing but still maturing enforcement tradition. EU competition law benefits from decades of established jurisprudence, greater procedural transparency, and a more economically sophisticated analytical framework.

For foreign businesses, the question is not which competition law approach is superior, but how to navigate both effectively. Companies with operations in both jurisdictions should invest in dual compliance programs, engage local antitrust counsel with specific expertise in each regime, and approach competition law risk management as an integrated but jurisdictionally nuanced function. The most successful approach recognizes that China and the EU are converging on certain competition law standards while diverging on others, and tailors compliance strategies accordingly to the specific regulatory environment of each jurisdiction.